Importance of chemotherapy scheduling: Pieces of the puzzle

Cancer Investigation

Volumn 17, Issue 7, 1999, Pages 545-546

  Hryniuk, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ANTINEOPLASTIC ACTIVITY; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; EDITORIAL; HUMAN; PRIORITY JOURNAL; STEM CELL; UTERINE CERVIX CANCER;

EID: 0032835371     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909032864     Document Type: Editorial

References (8)

1. Lokich J. Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress. Cancer Invest 17:551-554, 1999.
2. Hryniuk WM: The importance of dose intensity in outcome of chemotherapy. In: Important Advances in Oncology, edited by S. Helman, V. Devita, S. Rosenberg. Philadelphia, Lippincott, 1988a, pp. 121-141.
3. Cavaletti G, Marzorati L, Bogliun G, et al: Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer 69:203-207, 1992.
4. Blomquist C, Elomaa I, Rissanen P, et al: Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration. J Clin Oncol 11:467-473, 1993.
5. Peters W, Jones R, Vredenburgh J, et al: A large prospective randomized trial of high-dose combination of alkylating agents (CPB) with autologous cellular support (ACMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM). Proc Am Soc Clin Oncol 15:121, 1996.
6. Chaudhary PM, Robinson IB: Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 85:632-639, 1993.
7. Hrushesky WJM: Circadian timing of cancer chemotherapy. Science 228:73-75, 1885.
8. Lévi F, Zidani R, Vannetzel J-M. et al: Chronomodulated vs fixed-infusion-rate delivery of ambulatory chemotherapy with oxalipsatin, fluorouracil, and folinic acid (leucovorin) in patients with collateral cancer metastases: a randomized multiinstitutional trial. J Natl Cancer Inst 86:1608-1617, 1994.